Drugs / Low Dose IHAT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06285799 | Mar 2024 → Feb 2025 | iron metabolism disease | Nemysis Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Low Dose IHAT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06285799 ↗ |
| Route | Oral | “evaluate orally-dosed Iron Hydroxide Adipate Tartrate (IHAT) at 2 different dose levels” NCT06285799 ↗ |